Morepen Laboratories Ltd

Morepen Laboratories Ltd has surged to a fresh 52-week high of Rs 126.9 on 21 Sep 2026, marking a remarkable rally that has more than tripled the stock price from its 52-week low of Rs 33.44. This milestone reflects a sustained momentum driven by a confluence of bullish technical indicators and consistent price appreciation over recent weeks.

Morepen Laboratories Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by touching an all-time high price of Rs.125.7 on 21 September 2026. This achievement reflects the company’s robust performance and sustained upward momentum in the stock market.

Morepen Laboratories Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 4 August 2026. While this rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 September 2026, providing investors with the latest insights into the company’s performance and outlook.

Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed one of the highest trading volumes on 18 Sep 2026, with over 60 lakh shares exchanging hands. Despite this surge in activity, the stock closed lower by 1.16%, underperforming both its sector and the broader Sensex, signalling a complex interplay of investor sentiment and market dynamics.

From a 52-week low of Rs 33.44 to a fresh high of Rs 123.5 on 18 Sep 2026, Morepen Laboratories Ltd has surged an impressive 119.6% over the past year, significantly outpacing the Sensex’s decline of 10.3%. This milestone caps a sustained rally fuelled by a confluence of strong technical indicators and robust price momentum.

Morepen Laboratories Ltd has reached a significant milestone by touching its all-time high price of Rs.123.50 on 18 September 2026, marking a remarkable phase in the company’s market performance within the Pharmaceuticals & Biotechnology sector.

Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a remarkable surge in trading volume and price momentum, signalling renewed investor interest and potential accumulation. The stock outperformed its sector and broader market indices on 17 Sep 2026, supported by strong delivery volumes and technical strength.

The Sensex gained 0.45% on 16 Sep 2026, yet Morepen Laboratories Ltd outpaced the broader market with a 7.39% surge, touching an intraday high of Rs 114.4. This 7.22 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.

Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed extraordinary trading volumes on 16 Sep 2026, even as its share price declined sharply. The stock’s recent upgrade from a Sell to a Hold rating by MarketsMOJO, combined with rising investor participation, paints a complex picture of market sentiment and accumulation dynamics.

Morepen Laboratories Ltd experienced a notable decline today, touching an intraday low of Rs 104.4, reflecting a sharp price pressure of -9.96% from its previous levels. The stock underperformed its sector and broader market indices amid heightened volatility and bearish market sentiment.

Morepen Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 September 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

From a 52-week low of Rs 33.44 to a fresh high of Rs 122.45 on 8 Sep 2026, Morepen Laboratories Ltd has surged an impressive 141.96% over the past year, significantly outperforming the Sensex which declined by 6.22% during the same period. This milestone reflects a powerful momentum shift underpinned by a confluence of technical indicators aligning strongly in favour of the stock’s upward trajectory.

Extending a remarkable rally that has seen its price multiply nearly fourfold over the past year, Morepen Laboratories Ltd touched a fresh all-time high of Rs 122.45 on 8 Sep 2026, underscoring a sustained bullish momentum that outpaces the broader market by a wide margin.

While the Sensex declined by 0.55% on 07 Sep 2026, Morepen Laboratories Ltd surged 7.08%, hitting an intraday high of Rs 120.95. This 5.43 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally in a broadly weak market environment.

From a 52-week low of Rs 33.44 to a fresh high of Rs 119.55 on 7 Sep 2026, Morepen Laboratories Ltd has surged an impressive 241% over the past year, significantly outpacing the Sensex’s decline of 5.67%. This remarkable rally is underpinned by a confluence of technical indicators signalling sustained momentum despite a broadly bearish market backdrop.

Morepen Laboratories Ltd has reached a significant milestone by touching its all-time high price on 07 Sep 2026, reflecting a strong upward trajectory driven by solid financial and technical performance within the Pharmaceuticals & Biotechnology sector.